Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 194

1.

Pseudoacromegaly.

Marques P, Korbonits M.

Front Neuroendocrinol. 2019 Jan;52:113-143. doi: 10.1016/j.yfrne.2018.11.001. Epub 2018 Nov 15. Review.

PMID:
30448536
2.

Standardization of Growth Hormone and Insulin-like Growth Factor-I Measurement.

Katsumata N.

Pediatr Endocrinol Rev. 2018 Sep;16(Suppl 1):28-32. doi: 10.17458/per.vol16.2018.k.standardizationmeasurementgh.

PMID:
30378780
3.

Embolic stroke, left atrial myxoma and gigantism in a patient with Carney complex with additional features suggestive of Marfan syndrome.

Micelli C, Diarsvitri W, Pia DM, Luhur H.

BMJ Case Rep. 2018 Aug 4;2018. pii: bcr-2018-225093. doi: 10.1136/bcr-2018-225093.

PMID:
30077980
4.

Head and neck manifestations of an undiagnosed McCune-Albright syndrome: clinicopathological description and literature review.

Lecumberri B, Pozo-Kreilinger JJ, Esteban I, Gomes M, Royo A, Gómez de la Riva Á, Pérez de Nanclares G.

Virchows Arch. 2018 Nov;473(5):645-648. doi: 10.1007/s00428-018-2396-z. Epub 2018 Jul 8. Review.

PMID:
29984378
5.

Resistant Paediatric Somatotropinomas due to AIP Mutations: Role of Pegvisomant.

Joshi K, Daly AF, Beckers A, Zacharin M.

Horm Res Paediatr. 2018;90(3):196-202. doi: 10.1159/000488856. Epub 2018 Jun 28.

PMID:
29953972
6.

An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations.

Trivellin G, Hernández-Ramírez LC, Swan J, Stratakis CA.

Best Pract Res Clin Endocrinol Metab. 2018 Apr;32(2):125-140. doi: 10.1016/j.beem.2018.02.004. Epub 2018 Mar 17. Review.

PMID:
29678281
7.

USE OF ELECTRONIC HEALTH RECORDS TO CHARACTERIZE A RARE DISEASE IN THE U.S.: TREATMENT, COMORBIDITIES, AND FOLLOW-UP TRENDS AMONG PATIENTS WITH A CONFIRMED DIAGNOSIS OF ACROMEGALY.

Silverstein JM, Roe ED, Munir KM, Fox JL, Emir B, Kouznetsova M, Lamerato LE, King D.

Endocr Pract. 2018 Jun;24(6):517-526. doi: 10.4158/EP-2017-0243. Epub 2018 Apr 6.

PMID:
29624099
8.

Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.

Hage M, Viengchareun S, Brunet E, Villa C, Pineau D, Bouligand J, Teglas JP, Adam C, Parker F, Lombès M, Tachdjian G, Gaillard S, Chanson P, Tosca L, Kamenický P.

J Clin Endocrinol Metab. 2018 May 1;103(5):1929-1939. doi: 10.1210/jc.2017-02287.

PMID:
29474559
9.

Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.

Nagata Y, Inoshita N, Fukuhara N, Yamaguchi-Okada M, Nishioka H, Iwata T, Yoshimoto K, Yamada S.

Pituitary. 2018 Feb;21(1):1-9. doi: 10.1007/s11102-017-0836-4.

PMID:
28849339
10.

In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism.

Salvatori R, Radian S, Diekmann Y, Iacovazzo D, David A, Gabrovska P, Grassi G, Bussell AM, Stals K, Weber A, Quinton R, Crowne EC, Corazzini V, Metherell L, Kearney T, Du Plessis D, Sinha AK, Baborie A, Lecoq AL, Chanson P, Ansorge O, Ellard S, Trainer PJ, Balding D, Thomas MG, Korbonits M.

Eur J Endocrinol. 2017 Sep;177(3):257-266. doi: 10.1530/EJE-17-0293. Epub 2017 Jun 20.

11.

Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study.

Tahara S, Murakami M, Kaneko T, Shimatsu A.

Endocr J. 2017 Jul 28;64(7):735-747. doi: 10.1507/endocrj.EJ16-0624. Epub 2017 Jul 8.

12.

Standardization of Growth Hormone and Insulin-like Growth Factor-I Measurements.

Katsumata N.

Pediatr Endocrinol Rev. 2017 Mar;14 Suppl 1(Suppl 1):209-215. doi: 10.17458/per.vol14.2017.k.standardizationgrowth. Review.

PMID:
28516748
13.

AIP mutations and gigantism.

Rostomyan L, Potorac I, Beckers P, Daly AF, Beckers A.

Ann Endocrinol (Paris). 2017 Jun;78(2):123-130. doi: 10.1016/j.ando.2017.04.012. Epub 2017 May 5. Review.

PMID:
28483363
14.

X-LAG: How did they grow so tall?

Beckers A, Rostomyan L, Potorac I, Beckers P, Daly AF.

Ann Endocrinol (Paris). 2017 Jun;78(2):131-136. doi: 10.1016/j.ando.2017.04.013. Epub 2017 Apr 27. Review.

15.

Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants.

Hernández-Ramírez LC, Trivellin G, Stratakis CA.

Horm Metab Res. 2017 Apr;49(4):286-295. doi: 10.1055/s-0043-104700. Epub 2017 Apr 20. Review.

PMID:
28427099
16.

A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.

Cansu GB, Taşkıran B, Trivellin G, Faucz FR, Stratakis CA.

Hormones (Athens). 2016 Jul;15(3):441-444. doi: 10.14310/horm.2002.1686.

17.

Acromegaly: clinical features at diagnosis.

Vilar L, Vilar CF, Lyra R, Lyra R, Naves LA.

Pituitary. 2017 Feb;20(1):22-32. doi: 10.1007/s11102-016-0772-8. Review.

PMID:
27812777
18.

Gigantism: X-linked acrogigantism and GPR101 mutations.

Iacovazzo D, Korbonits M.

Growth Horm IGF Res. 2016 Oct - Dec;30-31:64-69. doi: 10.1016/j.ghir.2016.09.007. Epub 2016 Sep 29. Review.

PMID:
27743704
19.

Screening for genetic causes of growth hormone hypersecretion.

Rostomyan L, Beckers A.

Growth Horm IGF Res. 2016 Oct - Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12. Review.

PMID:
27756606
20.

Novel Genetic Causes of Pituitary Adenomas.

Caimari F, Korbonits M.

Clin Cancer Res. 2016 Oct 15;22(20):5030-5042. Review.

Supplemental Content

Loading ...
Support Center